296 related articles for article (PubMed ID: 15249622)
1. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.
Koike H; Misu K; Sugiura M; Iijima M; Mori K; Yamamoto M; Hattori N; Mukai E; Ando Y; Ikeda S; Sobue G
Neurology; 2004 Jul; 63(1):129-38. PubMed ID: 15249622
[TBL] [Abstract][Full Text] [Related]
2. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.
Koike H; Kawagashira Y; Iijima M; Yamamoto M; Hattori N; Tanaka F; Hirayama M; Ando Y; Ikeda S; Sobue G
J Neurol; 2008 Oct; 255(10):1526-33. PubMed ID: 18821042
[TBL] [Abstract][Full Text] [Related]
4. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
[TBL] [Abstract][Full Text] [Related]
5. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form.
Koike H; Misu K; Ikeda S; Ando Y; Nakazato M; Ando E; Yamamoto M; Hattori N; Sobue G;
Arch Neurol; 2002 Nov; 59(11):1771-6. PubMed ID: 12433265
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan.
Sobue G; Koike H; Misu K; Hattori N; Yamamoto M; Ikeda S; Ando Y; Nakazato M; Inukai A
Amyloid; 2003 Aug; 10 Suppl 1():32-8. PubMed ID: 14640040
[TBL] [Abstract][Full Text] [Related]
7. Late-onset familial amyloid polyneuropathy in Japan.
Koike H; Sobue G
Amyloid; 2012 Jun; 19 Suppl 1():55-7. PubMed ID: 22506939
[TBL] [Abstract][Full Text] [Related]
8. Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy.
Koike H; Ikeda S; Takahashi M; Kawagashira Y; Iijima M; Misumi Y; Ando Y; Ikeda SI; Katsuno M; Sobue G
Neurology; 2016 Nov; 87(21):2220-2229. PubMed ID: 27794111
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.
Nagasaka T; Togashi S; Watanabe H; Iida H; Nagasaka K; Nakamura Y; Miwa M; Kobayashi F; Shindo K; Shiozawa Z
J Neurol Sci; 2009 Jan; 276(1-2):88-94. PubMed ID: 18930252
[TBL] [Abstract][Full Text] [Related]
10. Late-onset familial amyloid polyneuropathy: an autopsy study of two Japanese brothers.
Fujitake J; Mizuta H; Fujii H; Ishikawa Y; Katsuyama E; Takasu K; Saida K; Tatsuoka Y
Amyloid; 2003 Sep; 10(3):198-205. PubMed ID: 14640033
[TBL] [Abstract][Full Text] [Related]
11. The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study.
Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sakurai T; Shimohata T; Katsuno M; Sobue G
J Neurol Sci; 2018 Nov; 394():99-106. PubMed ID: 30243104
[TBL] [Abstract][Full Text] [Related]
12. [Clinical phenotype of Charcot-Marie-Tooth disease (CMT) and familial amyloid polyneuropathy (FAP)].
Sobue G
Rinsho Shinkeigaku; 2003 Nov; 43(11):769-74. PubMed ID: 15152460
[TBL] [Abstract][Full Text] [Related]
13. [Familial amyloid polyneuropathy: clinicopathological aspects].
Koike H; Sobue G
Brain Nerve; 2014 Jul; 66(7):749-62. PubMed ID: 24998820
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
[TBL] [Abstract][Full Text] [Related]
15. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
[TBL] [Abstract][Full Text] [Related]
17. Familial amyloid polyneuropathy associated with transthyretin Gly42 mutation: a quantitative light and electron microscopic study of the peripheral nervous system.
Toyooka K; Fujimura H; Ueno S; Yoshikawa H; Kaido M; Nishimura T; Yorifuji S; Yanagihara T
Acta Neuropathol; 1995; 90(5):516-25. PubMed ID: 8560986
[TBL] [Abstract][Full Text] [Related]
18. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.
Oshima T; Kawahara S; Ueda M; Kawakami Y; Tanaka R; Okazaki T; Misumi Y; Obayashi K; Yamashita T; Ohya Y; Ihse E; Shinriki S; Tasaki M; Jono H; Asonuma K; Inomata Y; Westermark P; Ando Y
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):740-6. PubMed ID: 24023270
[TBL] [Abstract][Full Text] [Related]
19. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
Ikeda S; Nakazato M; Ando Y; Sobue G
Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
[TBL] [Abstract][Full Text] [Related]
20. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
